（杂志篇）：肿瘤专业领域的4-5分杂志大梳理
继肿瘤专业领域的5-10分杂志大梳理后，我们今天梳理肿瘤专业领域的4-5分杂志。
今天主要介绍杂志Breast Cancer Research and Treatment，ONCOLOGIST，Carcinogenesis，Journal of Experimental & Clinical Cancer Research，Neoplasia和Cancer Research and Treatment。
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment是由SPRINGER出版社发行的半月刊杂志，年文章量为409，Breast Cancer Research and Treatment的影响因子持续在4-5分波动，近几年在缓缓下降，最新的影响因子是4.0分，预计影响因子会持续在4分-5分区间波动。
Breast Cancer Research and Treatment杂志的收录范围：
Breast Cancer Research and Treatment provides the surgeon， radiotherapist，medical oncologist，endocrinologist，epidemiologist，immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a 'market place' for breast cancer topics which cuts across all the usual lines of disciplines providing a site for presenting pertinent investigations and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
最新文章举例：
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.Breast Cancer Res Treat. 2016 Sep 28.
A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression.Breast Cancer Res Treat. 2016 Oct 5.
ONCOLOGIST
ONCOLOGIST是由 ALPHAMED PRESS出版社发行的月刊杂志，年文章量为189，ONCOLOGIST的影响因子波动还是比较大的，从2011年开始在4-5分缓缓上升，最新的影响因子是4.7分，2016年可能过5分。
ONCOLOGIST杂志的收录范围：
The Oncologist was established by oncologists to help physicians better manage their practices in a changing and challenging environment to guard against the future and ensure their patient's rights to the best health care possible. The Oncologist is devoted to medical and practice issues for surgical, radiation, and medical oncologists and is designed specifically for the busy practitioner entrusted with the care of adult or pediatric cancer patients.
最新文章举例：
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.Oncologist. 2016 Sep 30.
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer.Oncologist. 2016 Sep 28.
Carcinogenesis
Carcinogenesis是由 OXFORD UNIV PRESS出版社发行的月刊杂志，年文章量为180，Carcinogenesis的影响因子一直在5分上下波动，2014年还是5.3，2015年就变成了4.8，不过，从杂志的文章水平和文章量来看这个杂志的质量还是不错的，预计明年会进入5-10分领域，排进第三梯队。当然，别看现在不到5分，可能很多人宁愿投Carcinogenesis也不愿选oncotarget。
Carcinogenesis杂志的收录范围：
Carcinogenesis is a multi-disciplinary journal designed to bring together all the varied aspects of research which will ultimately lead to the prevention of cancer in man. the journal will publish full papers and short communications which warrant prompt publication in the areas of viral physical and chemical carcinogenesis and mutagenesis; factors modifying these processes such as DNA repair genetics and nutrition; metabolism of carcinogens; the mechanism of action of carcinogens and promoting agents; epidemiological studies; and the formation detection identification and quantification of environmental carcinogens. Accelerated papers are of important and timely work chosen by the editors which merit a fast review process followed by rapid publication (6 weeks). The editors may from time to time invite commentaries or short reviews.
最新文章举例：
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.Carcinogenesis. 2016 Sep 7.
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.Carcinogenesis. 2016 Sep 13.
Journal of Experimental & Clinical Cancer Research
Journal of Experimental & Clinical Cancer Research是由BIOMED CENTRAL LTD出版社发行的杂志，年文章量为155，JECCR的影响因子从2007年开始就一直蹭蹭蹭的坐火箭，根本停不下来，现在已经窜到了4.3分，比去年4.4稍微降了一点。如果杂志社坚持住这种高标准严要求，影响因子还可以再涨，期待JECCR过5分！
Journal of Experimental & Clinical Cancer Research杂志的收录范围：
Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology. Topics covered include:
Hematology
Molecular and cellular pathology
Oncogenomics, proteomics and metabolomics
Microenviroment
Therapeutics and targets
Tumor and stem cell biology
Tumor immunology and virology
最新文章举例：
TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.J Exp Clin Cancer Res. 2016 Sep 27;35(1):152.
TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.J Exp Clin Cancer Res. 2016 Sep 20;35(1):148.
Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells.J Exp Clin Cancer Res. 2016 Sep 19;35(1):147.
Neoplasia
Neoplasia是由 ELSEVIER SCIENCE INC出版社发行的双月刊杂志，年文章量为81，年文章量太少了，命中率为18.33% 也不高。Neoplasia的影响因子一直在4-6分区间波动，这两年维持在4.5左右，文章量越少，波动范围越大。
Neoplasia杂志的收录范围：
Neoplasia is published bimonthly. Neoplasia publishes the results of novel investigations in all areas of oncology research. The journal encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype. Laboratory and clinical studies will also be an important part of the journal's coverage where creative applications of the advances in the basic science to risk assessment, prognostic indications, detection, diagnosis, and treatment are demonstrated. In addition to regular Research Articles, the journal also publishes Brief Articles, Reviews, and Meeting Articles.
最新文章举例：
CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.Neoplasia. 2016 Sep 27;18(10):636-646.
ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21.Neoplasia. 2016 Sep 24;18(10):626-635.
Cancer Research and Treatment
Cancer Research and Treatment是韩国肿瘤协会出版的季刊杂志，一年只有一卷，从medsci上大家投稿经验来看，接收率只有5%，还是很挑稿子的，可能也正因为如此，影响因子以每年1分的速度一直升，2015年达到了4.2，这样下去估计还会涨，希望保持住。
从接收的文章上看，怎么作者都是韩国人啊，怎么这么没有国际视野呢？
Cancer Research and Treatment杂志的收录范围：
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.
最新文章举例：
Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.Cancer Res Treat. 2016 Sep 1.
Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes Among Korean Breast Cancer Patients.Cancer Res Treat. 2016 Sep 13.
That's all. Thank you!
请关注“小张聊科研”：搜索微信号“xzlky2015”，或长按二维码识别关注。
↓↓↓